Trials / Completed
CompletedNCT01847248
HSPA12B as a Potential Biomarker for Sepsis and Severe Sepsis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 118 (actual)
- Sponsor
- Changhai Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
* Molecules indicating endothelial injury may serve as biomarkers for severe sepsis because of the critical role of endothelial injury in organ dysfunction during severe sepsis. * HSPA12B is primarily located in endothelial cells and detectable during sepsis. * The investigators speculated that HSPA12B from endothelial cells might be correlated with severe sepsis.
Conditions
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2013-03-01
- Completion
- 2013-10-01
- First posted
- 2013-05-06
- Last updated
- 2013-11-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01847248. Inclusion in this directory is not an endorsement.